These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dermal, serological and CSF changes in amyotrophic lateral sclerosis with and without intrathecal interferon beta treatment. Westarp ME; Westphal KP; Kolde G; Wollinsky KH; Westarp MP; Dickob M; Kornhuber HH Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):81-93. PubMed ID: 1506122 [TBL] [Abstract][Full Text] [Related]
5. Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlates. Dabby R; Sadeh M; Herman O; Berger E; Watemberg N; Hayek S; Jossiphov J; Nevo Y Isr Med Assoc J; 2006 Feb; 8(2):110-3. PubMed ID: 16544734 [TBL] [Abstract][Full Text] [Related]
6. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653 [TBL] [Abstract][Full Text] [Related]
7. Creatine kinase and fibrillation potentials in patients with late sequelae of polio. Nelson KR Muscle Nerve; 1990 Aug; 13(8):722-5. PubMed ID: 2385258 [TBL] [Abstract][Full Text] [Related]
8. Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Hama T; Hirayama M; Hara T; Nakamura T; Atsuta N; Banno H; Suzuki K; Katsuno M; Tanaka F; Sobue G Muscle Nerve; 2012 Feb; 45(2):169-74. PubMed ID: 22246870 [TBL] [Abstract][Full Text] [Related]
9. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585 [TBL] [Abstract][Full Text] [Related]
10. Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels. Simmons Z; Peterlin BL; Boyer PJ; Towfighi J Muscle Nerve; 2003 Feb; 27(2):242-4. PubMed ID: 12548533 [TBL] [Abstract][Full Text] [Related]
12. Creatine kinase level and its relationship with quantitative electromyographic characteristics in amyotrophic lateral sclerosis. Tai H; Cui L; Liu M; Guan Y; Li X; Shen D; Zhang K; Liu S; Wu S; Ding Q; Hu Y Clin Neurophysiol; 2018 May; 129(5):926-930. PubMed ID: 29550653 [TBL] [Abstract][Full Text] [Related]
13. Prevention of muscle disuse atrophy by low-frequency electrical stimulation in rats. Dupont Salter AC; Richmond FJ; Loeb GE IEEE Trans Neural Syst Rehabil Eng; 2003 Sep; 11(3):218-26. PubMed ID: 14518784 [TBL] [Abstract][Full Text] [Related]
17. Single motor unit variability with threshold stimulation in patients with amyotrophic lateral sclerosis and normal subjects. Jillapalli D; Shefner JM Muscle Nerve; 2004 Nov; 30(5):578-84. PubMed ID: 15452842 [TBL] [Abstract][Full Text] [Related]
18. Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients. Borgia D; Malena A; Spinazzi M; Desbats MA; Salviati L; Russell AP; Miotto G; Tosatto L; Pegoraro E; Sorarù G; Pennuto M; Vergani L Hum Mol Genet; 2017 Mar; 26(6):1087-1103. PubMed ID: 28087734 [TBL] [Abstract][Full Text] [Related]
19. Myokymic discharges in amyotrophic lateral sclerosis (ALS): a rare electrophysiologic finding? Whaley NR; Rubin DI Muscle Nerve; 2010 Jan; 41(1):107-9. PubMed ID: 20014246 [TBL] [Abstract][Full Text] [Related]
20. [Muscle fiber type abnormalities in bulbospinal muscular atrophy. Comparison with amyotrophic lateral sclerosis]. Kojima S; Takagi A; Ida M; Nozawa T; Shiozawa R Rinsho Shinkeigaku; 1989 Apr; 29(4):427-31. PubMed ID: 2612097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]